相似文献
1
Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i67-71. doi: 10.1136/gut.51.suppl_1.i67.
2
Visceral hypersensitivity.
J Clin Gastroenterol. 2005 May-Jun;39(5 Suppl 3):S194-203; discussion S210. doi: 10.1097/01.mcg.0000156114.22598.1b.
3
Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i34-40. doi: 10.1136/gut.51.suppl_1.i34.
4
Role of the brain and sensory pathways in gastrointestinal sensory disorders in humans.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i29-33. doi: 10.1136/gut.51.suppl_1.i29.
5
Visceral perception: inflammatory and non-inflammatory mediators.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i19-23. doi: 10.1136/gut.51.suppl_1.i19.
6
Pain produced by electric stimulation of the rectum in patients with irritable bowel syndrome: further evidence of visceral hyperalgesia.
Scand J Gastroenterol. 1999 Oct;34(10):1001-6. doi: 10.1080/003655299750025101.
7
[Visceral hypersensitivity of the large intestine mucosa in patients with irritable bowel syndrome--cause of the non-inflammatory changes in the pain syndrome].
Eksp Klin Gastroenterol. 2003(5):75-8, 195.
8
Hypersensitivity in functional gastrointestinal disorders.
Gut. 2002 Jul;51 Suppl 1(Suppl 1):i25-8. doi: 10.1136/gut.51.suppl_1.i25.
9
Sensitivity and distensibility of the rectum and sigmoid colon in patients with irritable bowel syndrome.
Scand J Gastroenterol. 2001 Aug;36(8):827-32. doi: 10.1080/003655201750313351.
10
Dimensions of gut dysfunction in irritable bowel syndrome: altered sensory function.
Can J Gastroenterol. 1999 Mar;13 Suppl A:12A-14A. doi: 10.1155/1999/963469.
引用本文的文献
1
Increase in circulating GLP-1 following low FODMAP diet in irritable bowel syndrome patients.
Front Nutr. 2025 Aug 13;12:1615671. doi: 10.3389/fnut.2025.1615671. eCollection 2025.
2
Diagnostic Value of Fecal Lactoferrin in Differentiating Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Comparative Study in a Bangladeshi Cohort.
Cureus. 2025 Apr 13;17(4):e82187. doi: 10.7759/cureus.82187. eCollection 2025 Apr.
3
Exploration of differential responses to FODMAPs and gluten in people with irritable bowel syndrome- a double-blind randomized cross-over challenge study.
Metabolomics. 2024 Feb 12;20(2):21. doi: 10.1007/s11306-023-02083-x.
4
Systematic Review on Herbal Preparations for Controlling Visceral Hypersensitivity in Functional Gastrointestinal Disorders.
Curr Pharm Biotechnol. 2024;25(13):1632-1650. doi: 10.2174/0113892010261502231102040149.
5
Non-pharmacologic approaches to treatment of pediatric functional abdominal pain disorders.
Front Pediatr. 2023 Jun 15;11:1118874. doi: 10.3389/fped.2023.1118874. eCollection 2023.
6
From In Vitro to In Vivo: A Rational Flowchart for the Selection and Characterization of Candidate Probiotic Strains in Intestinal Disorders.
Microorganisms. 2023 Mar 30;11(4):906. doi: 10.3390/microorganisms11040906.
7
Similarities and differences in constipation phenotypes between Lep knockout mice and high fat diet-induced obesity mice.
PLoS One. 2022 Dec 22;17(12):e0276445. doi: 10.1371/journal.pone.0276445. eCollection 2022.
8
The effect of self-management online modules plus nurse-led support on pain and quality of life among young adults with irritable bowel syndrome: A randomized controlled trial.
Int J Nurs Stud. 2022 Aug;132:104278. doi: 10.1016/j.ijnurstu.2022.104278. Epub 2022 Apr 30.
9
Psychological Predictors of Response to Open-Label Versus Double-Blind Placebo in a Randomized Controlled Trial in Irritable Bowel Syndrome.
Psychosom Med. 2022;84(6):738-746. doi: 10.1097/PSY.0000000000001078. Epub 2022 Apr 12.
10
Pathophysiological Commonality Between Irritable Bowel Syndrome and Metabolic Syndrome: Role of Corticotropin-releasing Factor-Toll-like Receptor 4-Proinflammatory Cytokine Signaling.
J Neurogastroenterol Motil. 2022 Apr 30;28(2):173-184. doi: 10.5056/jnm21002.
本文引用的文献
1
The irritable colon syndrome. A study of the clinical features, predisposing causes, and prognosis in 130 cases.
Q J Med. 1962 Jul;31:307-22.
2
Intrarectal injection of glycerol induces hypersensitivity to rectal distension in healthy subjects without modifying rectal compliance.
Eur J Gastroenterol Hepatol. 2001 May;13(5):573-80. doi: 10.1097/00042737-200105000-00018.
3
Gender differences in regional brain response to visceral pressure in IBS patients.
Eur J Pain. 2000;4(2):157-72. doi: 10.1053/eujp.2000.0167.
4
Effects of alosetron on gastrointestinal transit time and rectal sensation in patients with irritable bowel syndrome.
Aliment Pharmacol Ther. 2000 Jul;14(7):869-78. doi: 10.1046/j.1365-2036.2000.00786.x.
5
Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention.
Gastroenterology. 2000 May;118(5):842-8. doi: 10.1016/s0016-5085(00)70170-3.
6
Putative inflammatory and immunological mechanisms in functional bowel disorders.
Baillieres Best Pract Res Clin Gastroenterol. 1999 Oct;13(3):429-36. doi: 10.1053/bega.1999.0037.
7
Principles of applied neurogastroenterology: physiology/motility-sensation.
Gut. 1999 Sep;45 Suppl 2(Suppl 2):II17-24. doi: 10.1136/gut.45.2008.ii17.
8
Influence of age on rectal tone and sensitivity to distension in healthy subjects.
Neurogastroenterol Motil. 1999 Apr;11(2):101-7. doi: 10.1046/j.1365-2982.1999.00145.x.
9
The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome.
Gastroenterology. 1999 Jan;116(1):38-45. doi: 10.1016/s0016-5085(99)70226-x.
10
Subtypes of constipation predominant irritable bowel syndrome based on rectal perception.
Gut. 1998 Sep;43(3):388-94. doi: 10.1136/gut.43.3.388.
Zotero 插件